LIFEVANTAGE CORP Lessee, Operating Lease, Liability, Undiscounted Excess Amount
LIFEVANTAGE CORP (LFVN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $860.00 thousand as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-27
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $860.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $930.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.06M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.10M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $860.00K 10-K · filed 2026-08-27 |
| 2026-03-31 | $930.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.06M 10-Q · filed 2026-02-04 |
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.20M 10-K · filed 2025-09-04 |
| 2025-03-31 | $1.34M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.44M 10-Q · filed 2025-02-05 |
| 2024-09-30 | $1.15M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $1.24M 10-K · filed 2024-08-28 |
| 2024-03-31 | $1.65M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.68M 10-Q · filed 2024-01-30 |
| 2023-09-30 | $1.87M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.89M 10-K · filed 2023-08-28 |
| 2023-03-31 | $2.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.10M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $2.50M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $2.36M 10-K · filed 2022-08-23 |
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $2.64M 10-Q · filed 2022-02-01 |
| 2021-09-30 | $2.36M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.47M 10-K · filed 2021-08-19 |
| 2021-03-31 | $3.03M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $3.17M 10-Q · filed 2021-02-02 |
| 2020-09-30 | $3.17M 10-Q · filed 2020-11-03 |
| 2020-06-30 | -$17.00K 10-K · filed 2020-08-18 |
| 2020-03-31 | $33.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $58.00K 10-Q · filed 2020-01-28 |
| 2019-09-30 | $73.00K 10-Q · filed 2019-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |